ASTRAZENECA PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 10.3%
Tue, 21 Aug

ASTRAZENECA PHARMA has announced its results for the quarter ended June 2018. Here is a detailed performance review of the same:

ASTRAZENECA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-17*
3
Mar-18*
3
Jun-18*
QoQ ChangeYoY Change
Net SalesRs m1,2851,5071,6147.1%25.7%
Other incomeRs m47233446.4%-26.5%
TurnoverRs m1,3311,5311,6497.7%23.8%
ExpensesRs m1,2221,3551,52212.3%24.5%
Gross profitRs m6215393-39.2%49.3%
DepreciationRs m3736360.0%-4.3%
InterestRs m0000.0%0.0%
Profit before taxRs m7214192-34.9%27.8%
TaxRs m1410828-74.5%102.0%
Profit after taxRs m58326498.4%10.3%
Gross profit margin%4.810.15.7
Effective tax rate%19.177.130.1
Net profit margin%4.42.13.9
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 25.7% on a year-on-year (YoY) basis. The expenses were up by 24.5% YoY during the same period.
  • The company's operating profit increased by 49.3% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 5.7% in 1QFY19 as against 4.8% in 1QFY18.
  • Depreciation charges and finance costs declined by 4.3% YoY and 0.0% YoY, respectively.
  • Other income declined by 26.5% YoY during the quarter.
  • Net profit for the quarter increased by 10.3% YoY. Net profit margins during the quarter declined from 4.4% in 1QFY18 to 3.9% in 1QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 7.1% on a quarter-on-quarter (QoQ) basis. The expenses were up by 12.3% QoQ during the same period.
  • The company's operating profit declined by 39.2% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 5.7% in 1QFY19 as against 10.1% in 4QFY18.
  • Net profit for the quarter increased by 98.4% QoQ, while net profit margins increased from 2.1% in 4QFY18 to 3.9% in 1QFY19.

To see how ASTRAZENECA PHARMA has performed over the last eight quarters, please visit here.

ASTRAZENECA PHARMA Share Price Performance

Over the last one year, ASTRAZENECA PHARMA share price has moved up from Rs 898.5 to Rs 1,814.0, registering a Gain of Rs 915.6 or around 101.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 15,319.2 (up 1.2%). Over the last one year it has moved up from 12,730.1 to 15,319.2, a gain of 2,589 points (up 20.3%).

Overall, the S&P BSE SENSEX is up 22.5% over the year.

Current Valuations

At the current price of Rs 1,814.0, the price to earnings (P/E) ratio of ASTRAZENECA PHARMA stands at 170.2 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 26.4 times.